• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT Back to Search Results
Catalog Number 788426
Medical Device Problem Code Difficult to Insert (1316)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/24/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that it seems that the surface of inlay ureteral stent was too dry.It was too hard to insert stent when inserting patient body.Physician felt that it was too hard to insert stent when inserting patient's body.(lot#ngjs2407) and (lot#ngjr2318).
 
Event or Problem Description
It was reported that it seems that the surface of inlay ureteral stent was too dry.It was too hard to insert stent when inserting patient body.Physician felt that it was too hard to insert stent when inserting patient's body.(lot #ngjs2407) and (lot #ngjr2318).
 
Additional Manufacturer Narrative
The reported event is inconclusive.Visual: the submitted with the original bard inlay box and pouch and was enclosed in a large ziploc bag.The suture and pigtail straightener were not included for evaluation.Visual requirements states to "use unaided eye at 12" to 18" distance under normal room lighting, unless otherwise noted." dimensional requirements states the od of the stent is to be 0.061" ± 0.002", and the guidewire used is to be 0.035" ± 0.001." upon evaluation of the sample, no defects were observed on the stent itself.Tactile inspection revealed no noticeable difference between the two submitted stent and comparable products.The suture and pigtail straightener had been removed prior to submissions and were not included for evaluation.The outer diameter of the stent was measured 0.0619" using a laser micrometer.A 0.035" guidewire was successfully passed through the stent without resistance.The complaint could not be confirmed, no defects were evaluated.Also received 2 photo samples which shows top view of product packaging.The reported event was inconclusive as it is unknown how the product interacted with the patient's anatomy.No additional actions are required at this time.A dhr review did not show any problems or conditions that would have contributed to the reported event.The instructions for use were found adequate and state the following: "precautions: suture may be cut off prior to stent placement.Remove suture if indwelling time is expected to be longer than 14 days.Avoid improper handling of stent such as bending, kinking, tearing etc.Misuse could damage the overall integrity of the stent.Ureteral stents should be checked periodically for signs of encrustation and proper function.Periodic checks of the stent by cystoscopic and or radiographic procedures are recommended at intervals deemed to be appropriate by the physician in consideration of the individual patient's condition and other patient specific factors.When long-term use is indicated, it is recommended that indwelling time not exceed 365 days.The stent is not intended as a permanent indwelling device.With any ureteral stent, migration is a possible complication, which could require medical intervention for removal.Selection of too short a stent may result in migration.Care should be exercised when removing the stent from the inner polybag to eliminate tearing or fragmentation.The insertion of a ureteral stent should only be done by those individuals who have comprehensive training in the techniques and risks of the procedure.Multi-length ureteral stents: formation of knots in multi-length ureteral stents may occur.This may result in injury to the ureter during removal and or the need for additional surgical intervention.The presence of knot should be considered if significant resistance is encountered during attempts at removal.Warning: after use, this product may be a potential biohazard.Handle and dispose of in accordance with accepted medical practice and with applicable local, state and federal laws and regulations.This is a single use device.Do not re-sterilize any portion of this device.Reuse and or repackaging may create a risk of patient or user infection, compromise the structural integrity and or essential material and design characteristics of the device, which may lead to device failure, and or lead to injury, illness or death of the patient." correction: d, e, h.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT
Common Device Name
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key21167674
Report Number1018233-2024-08771
Device Sequence Number9545759
Product Code FAD
UDI-Device Identifier00801741015687
UDI-Public(01)00801741015687(11)240624(17)281031(10)NGJS2407
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/26/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number788426
Device Lot NumberNGJS2407
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/26/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/26/2024
Supplement Date Received by Manufacturer06/27/2025
Initial Report FDA Received Date01/16/2025
Supplement Report FDA Received Date06/30/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/24/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-